Drug application
CARBOPROST TROMETHAMINE (CARBOPROST TROMETHAMINE)
Drugs@FDA ANDA 219529 · SOMERSET THERAPS LLC
Key facts
| Drug name | CARBOPROST TROMETHAMINE |
|---|---|
| Active ingredients | CARBOPROST TROMETHAMINE |
| Application type | ANDA |
| Application number | 219529 |
| Company | SOMERSET THERAPS LLC |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | EQ 0.25MG BASE/ML |
| Marketing status | Prescription |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | May 27, 2026 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 10–99 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.